Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease (Annals of Neurology, 2025)

(untitled) - Ceronie, B; Strippel, C; Uy, C; Paneva, S; Makuch, M; Soleimani, B; Turaga, S; Binks, S; Ramanathan, S; Michael, S; Varley, J; Easton, A; et al.